Results 261 to 270 of about 732,506 (308)
Circulating Biomarkers and Targeted Therapy in Pleural Mesothelioma. [PDF]
Grant CR, Bazhenova L, Yun KM.
europepmc +1 more source
Radiolabeling molecular biomarkers of invasive pituitary adenomas: a narrative review. [PDF]
Marche C +6 more
europepmc +1 more source
Multimodal deep learning for bone tumor diagnosis with clinical imaging, pathology, and blood biomarkers. [PDF]
Sang H +9 more
europepmc +1 more source
Extracellular derived-exosomal micrornas in pancreatic cancer: investigating their diagnostic importance and potential targets for the prevention and treatment in pancreatic cancer. [PDF]
Mir R +16 more
europepmc +1 more source
Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and Surveillance. [PDF]
Yang Z, Song F, Zhong J.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Urinary Biomarkers in Tumors: An Overview
2021Recent reports suggest that urine is a useful noninvasive tool for the identification of urogenital tumors, including bladder, prostate, kidney, and other nonurological cancers. As a liquid biopsy, urine represents an important source for the improvement of new promising biomarkers, a suitable tool to identify indolent cancer and avoid overtreatment ...
Ilaria, Cimmino +2 more
openaire +2 more sources
Biomarkers of neuroendocrine tumors
Annales de biologie clinique, 2016Neuroendocrine tumors (NET) are rare heterogenous tumors which prevalence is increasing. Their features vary by anatomical location, functionality and hormonal production. Their management needs a multidisciplinary approach. Functional tumors develop characteristic clinical syndromes in contrast to non-functional tumors that are diagnosed fortuitously ...
Michèle, d'Herbomez +5 more
openaire +2 more sources
International Journal of Oncology, 1996
Despite advances and improvements in diagnosis and treatment of upper aerodigestive tumors including head and neck and lung cancers, the overall survival rate of these patients remains poor. Prevention, early diagnosis, and novel therapy are under active investigation to improve the outcome of the diseases.
D, Shin, W, Hong
openaire +2 more sources
Despite advances and improvements in diagnosis and treatment of upper aerodigestive tumors including head and neck and lung cancers, the overall survival rate of these patients remains poor. Prevention, early diagnosis, and novel therapy are under active investigation to improve the outcome of the diseases.
D, Shin, W, Hong
openaire +2 more sources

